Intravitreous injection of bevacizumab and C3F8 gas for the treatment of submacular hemorrhage due to age-related macular degeneration: Case reports;Injeção intravítrea de bevacizumab e gás C3F8 para tratamento da hemorragia submacular secundária a degeneração macular relacionada à idade: Relato de casos

Arquivos Brasileiros de Oftalmologia

Volumn 73, Issue 1, 2010, Pages 77-80

  Ferraz, Daniel Araújo ^a   Bressanim, Gláucio Luciano ^a   Morita, Celso ^a   Takahashi, Walter Yukihiko ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiogenesis inhibitors therapeutic use; Case reports; Choroidal neovascularization; Fluorocarbons therapeutic use; Gases therapeutic use; Human; Injections; Macular degeneration complications; Retinal hemorrhage; Retinal vein occlusion; Visual acuity

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; FLUOROCARBON; MONOCLONAL ANTIBODY; PERFLUTREN;

AGED; ARTICLE; CASE REPORT; FEMALE; HOSPITALIZATION; HUMAN; INTRAOCULAR DRUG ADMINISTRATION; MALE; METHODOLOGY; MIDDLE AGED; RETINA FOVEA; RETINA HEMORRHAGE; RETINA MACULA DEGENERATION; RETROSPECTIVE STUDY; VISUAL ACUITY; VITREOUS BODY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FEMALE; FLUOROCARBONS; FOVEA CENTRALIS; HUMANS; INJECTIONS, INTRAOCULAR; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETINAL HEMORRHAGE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VISUAL ACUITY; VITREOUS BODY;

EID: 77954937839     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/S0004-27492010000100014     Document Type: Article

References (10)

1. Berrocal MH, Lewis ML, Flynn HW Jr. Variations in the clinical course of submacular hemorrhage. Am J Ophthalmol. 1996;122(4):486-93. Erratum in: Am J Ophthalmol. 122(6):920.
2. Avery RL, Fekrat S, Hawkins BS, Bressler NM. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina. 1996; 16(3):183-9.
3. Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol. 1982;94(6):762-73.
4. Hesse L, Schmidt J, Kroll P. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefes Arch Clin Exp Ophthalmol. 1999;237(4):273-7.
5. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP Report 1. Treatment of age-relatede macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol. 1999;117(10): 1329-45. Erratum in: Arch Ophthalmol. 2000;118(4):488. Comment in: Arch Ophthalmol. 1999;117(10):1400-2. Arch Ophthalmol. 2001;119(1):143. Arch Ophthalmol. 2002;120(6):872.
6. Handwerger BA, Blodi BA, Chandra SR, Olsen TW, Stevens TS. Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement. Arch Ophthalmol. 2001;119(1):28-32. Comment in: Arch Ophthalmol. 2002;120(1):102-3; author reply 203.
7. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006:355(14):1419-31. Comment in: N Engl J Med. 2006;355(14):1409-12. N Engl J Med. 2006;355(14):1493-5. N Engl J Med. 2007;356(7):747-8; author reply 749-50, N Engl J Med. 2007;356(7): 748-9; author reply 749-50.
8. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S; ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14): 1432-44. Comment in: N Engl J Med. 2006;355(14):1409-12. N Eng J Med. 2006;355(14):493-5. N Engl J Med. 2007;356(7):747-8; author reply 749-50. N Engl J Med. 2007; 356(7):748-9; author reply 749-50.
9. Soliman W, Lund-Andersen H, Larsen M. Resolution of subretinal hemorrhage and fluid after intravitreal bevacizumab in aggressive peripapillary subretinal neovascularization. Acta Ophthalmol Scand. 2006;84(5):707-8.
10. Wu L, Martinez-Castellanos MA, Quiroz-Mercado H, Averalo JF, Berrocal MH, Farah ME, Maia M, Roca JÁ, Rodrigues FJ, Pan American Collaborative Retina Group (PACORES). Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol. 2008;246(1):81-7.